Carderock Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Sell |
20,860
-409
| -2% | -$196K | 2.29% | 15 |
|
|
2026
Q1 | $10.5M | Buy |
21,269
+252
| +1% | +$137K | 2.58% | 9 |
|
|
2025
Q4 | $12.2M | Buy |
21,017
+5,662
| +37% | +$3.2M | 2.95% | 8 |
|
|
2025
Q3 | $7.45M | Buy |
15,355
+1,396
| +10% | +$650K | 1.81% | 28 |
|
|
2025
Q2 | $5.66M | Buy |
13,959
+365
| +3% | +$153K | 1.45% | 37 |
|
|
2025
Q1 | $6.76M | Buy |
13,594
+1,262
| +10% | +$683K | 1.79% | 33 |
|
|
2024
Q4 | $6.42M | Sell |
12,332
-308
| -2% | -$169K | 1.61% | 34 |
|
|
2024
Q3 | $7.82M | Buy |
12,640
+754
| +6% | +$446K | 1.85% | 28 |
|
|
2024
Q2 | $6.57M | Buy |
11,886
+369
| +3% | +$211K | 1.72% | 34 |
|
|
2024
Q1 | $6.69M | Sell |
11,517
-1,196
| -9% | -$671K | 1.88% | 31 |
|
|
2023
Q4 | $6.75M | Buy |
12,713
+319
| +3% | +$154K | 1.86% | 29 |
|
|
2023
Q3 | $6.27M | Sell |
12,394
-934
| -7% | -$498K | 2.11% | 25 |
|
|
2023
Q2 | $6.95M | Sell |
13,328
-1,355
| -9% | -$731K | 2.16% | 20 |
|
|
2023
Q1 | $8.46M | Sell |
14,683
-1,999
| -12% | -$1.13M | 2.95% | 5 |
|
|
2022
Q4 | $9.19M | Sell |
16,682
-79
| -0.5% | -$41.9K | 3.81% | 3 |
|
|
2022
Q3 | $8.5M | Sell |
16,761
-705
| -4% | -$395K | 4.34% | 2 |
|
|
2022
Q2 | $9.49M | Sell |
17,466
-1,248
| -7% | -$687K | 3.96% | 3 |
|
|
2022
Q1 | $11.1M | Sell |
18,714
-640
| -3% | -$368K | 3.57% | 3 |
|
|
2021
Q4 | $12.9M | Buy |
19,354
+874
| +5% | +$546K | 3.1% | 5 |
|
|
2021
Q3 | $10.6M | Sell |
18,480
-14
| -0.1% | -$7.68K | 2.98% | 9 |
|
|
2021
Q2 | $9.33M | Buy |
18,494
+60
| +0.3% | +$28.3K | 2.56% | 9 |
|
|
2021
Q1 | $8.41M | Sell |
18,434
-5,360
| -23% | -$2.56M | 2.51% | 7 |
|
|
2020
Q4 | $11.1M | Buy |
23,794
+57
| +0.2% | +$26.7K | 3.35% | 4 |
|
|
2020
Q3 | $10.5M | Sell |
23,737
-732
| -3% | -$302K | 3.54% | 3 |
|
|
2020
Q2 | $8.87M | Sell |
24,469
-816
| -3% | -$274K | 3.27% | 5 |
|
|
2020
Q1 | $7.17M | Sell |
25,285
-316
| -1% | -$99.6K | 3.29% | 2 |
|
|
2019
Q4 | $8.32M | Sell |
25,601
-1,327
| -5% | -$402K | 2.79% | 5 |
|
|
2019
Q3 | $7.84M | Sell |
26,928
-626
| -2% | -$179K | 2.89% | 4 |
|
|
2019
Q2 | $8.09M | Sell |
27,554
-349
| -1% | -$96.1K | 3.05% | 3 |
|
|
2019
Q1 | $7.64M | Buy |
27,903
+203
| +0.7% | +$50.5K | 3.12% | 4 |
|
|
2018
Q4 | $6.2M | Sell |
27,700
-689
| -2% | -$162K | 3.2% | 3 |
|
|
2018
Q3 | $6.93M | Buy |
28,389
+39
| +0.1% | +$8.97K | 2.73% | 6 |
|
|
2018
Q2 | $5.87M | Sell |
28,350
-107
| -0.4% | -$22.7K | 2.53% | 9 |
|
|
2018
Q1 | $5.88M | Sell |
28,457
-251
| -0.9% | -$52.7K | 2.59% | 8 |
|
|
2017
Q4 | $5.45M | Sell |
28,708
-4,625
| -14% | -$886K | 2.4% | 9 |
|
|
2017
Q3 | $6.31M | Buy |
33,333
+4,143
| +14% | +$750K | 2.85% | 6 |
|
|
2017
Q2 | $5.09M | Buy |
29,190
+200
| +0.7% | +$33.6K | 2.3% | 12 |
|
|
2017
Q1 | $4.45M | Sell |
28,990
-1,316
| -4% | -$201K | 2.06% | 19 |
|
|
2016
Q4 | $4.28M | Buy |
30,306
+363
| +1% | +$53.5K | 2.13% | 16 |
|
|
2016
Q3 | $4.76M | Buy |
29,943
+381
| +1% | +$58.7K | 2.38% | 11 |
|
|
2016
Q2 | $4.37M | Sell |
29,562
-545
| -2% | -$80.4K | 2.31% | 16 |
|
|
2016
Q1 | $4.26M | Buy |
30,107
+43
| +0.1% | +$5.76K | 2.19% | 20 |
|
|
2015
Q4 | $4.26M | Buy |
30,064
+1,141
| +4% | +$152K | 2.22% | 17 |
|
|
2015
Q3 | $3.54M | Buy |
28,923
+170
| +0.6% | +$22.1K | 1.97% | 22 |
|
|
2015
Q2 | $3.73M | Buy |
28,753
+119
| +0.4% | +$15.5K | 1.87% | 22 |
|
|
2015
Q1 | $3.85M | Buy |
28,634
+68
| +0.2% | +$8.77K | 1.86% | 25 |
|
|
2014
Q4 | $3.58M | Buy |
28,566
+29
| +0.1% | +$3.53K | 1.76% | 28 |
|
|
2014
Q3 | $3.47M | Buy |
28,537
+7,432
| +35% | +$904K | 1.78% | 25 |
|
|
2014
Q2 | $2.49M | Buy |
21,105
+78
| +0.4% | +$9.18K | 1.3% | 32 |
|
|
2014
Q1 | $2.53M | Buy |
21,027
+1,908
| +10% | +$227K | 1.28% | 31 |
|
|
2013
Q4 | $2.13M | Sell |
19,119
-5,730
| -23% | -$570K | 1.12% | 38 |
|
|
2013
Q3 | $2.29M | Buy |
24,849
+316
| +1% | +$28.6K | 1.33% | 33 |
|
|
2013
Q2 | $2.08M | Buy |
+24,533
| New | +$2.04M | 1.23% | 36 |
|
Other funds holding TMO
RG
ECSS
LT
Carderock Capital Management's TMO Position: Q2 2026 in Review
Carderock Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $196K and leaving 20,860 shares worth $10.5M. The position accounts for 2.29% of the portfolio, ranked #15.
Carderock Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.9M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Carderock Capital Management held 20,860 shares of Thermo Fisher Scientific worth $10.5M as of Q2 2026.
- Carderock Capital Management sold 409 Thermo Fisher Scientific shares in Q2 2026, an estimated $196K.
- Thermo Fisher Scientific made up 2.29% of Carderock Capital Management's portfolio in Q2 2026, its #15 holding.
- Carderock Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Carderock Capital Management's Thermo Fisher Scientific position peaked at $12.9M in Q4 2021.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.